Subscribe To
transcode therapeutics withdraws public offering
BOSTON, Oct. 30, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company�...
October 30, 2023, 8:33 pm
Why is transcode therapeutics (rnaz) stock down 25% today?
transcode Therapeutics (NASDAQ: RNAZ ) stock is taking a beating on Friday after the oncology company ...
October 27, 2023, 8:16 am
transcontinental: cheap, thanks to sustainability investments and cost initiatives
transcontinental Inc. expects operating margin growth from cost initiatives and the deployment of radda...
October 3, 2023, 8:53 pm
transcode therapeutics announces closing of $8.5 million public offering
BOSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company...
September 28, 2023, 8:02 pm
Why is transcode therapeutics (rnaz) stock down 69% today?
transcode Therapeutics (NASDAQ: RNAZ ) stock is falling hard on Tuesday after the medical company anno...
September 26, 2023, 8:48 am
transcode therapeutic stock whipsaws lower after cut price placing
transcode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquarte...
September 26, 2023, 6:47 am
transcode therapeutics announces pricing of $8 million public offering
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Compan...
September 26, 2023, 12:01 am
Gold moves lower; transcode therapeutics shares surge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% ...
September 25, 2023, 6:59 pm
transcode therapeutics stock skyrockets on positive brain cancer trial results
transcode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study o...
September 25, 2023, 10:38 am
Ascendis pharma presents results from long-term enlighten trial of transcon™ hgh in pediatric growth hormone deficiency
– The majority of children and adolescents treated once weekly with transcon hGH (lonapegsomatropin) ...
September 23, 2023, 11:00 am
Williams (wmb) and the golden age for natural gas
Summary Several structural factors support growing natural gas demand, including its affordability, reliability, and emissions that are about half tha...
September 19, 2023, 1:21 pm
transcontinental inc. – release of third quarter 2023 results and conference call
MONTREAL, Aug. 23, 2023 (GLOBE NEWSWIRE) -- On Wednesday, September 6, 2023, transcontinental Inc. will...
August 23, 2023, 11:00 am
transcode therapeutics inc. (rnaz) may find a bottom soon, here's why you should buy the stock now
transcode Therapeutics Inc. (RNAZ) appears to have found support after losing some value lately, as ind...
July 10, 2023, 11:00 am
American realty: new multifamily property agreement and undervalued
American Realty Investors, Inc. reported a significant increase in assets, net income growth, and new agreements to develop a 240-unit multifamily pro...
July 8, 2023, 2:36 am
transcode therapeutics announces publication of new data supporting the use of ttx-mc138 for the treatment of metastatic breast cancer
BOSTON, June 22, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncolog...
June 22, 2023, 11:00 am
One-year data from phase 3 trial of transcon™ pth in adults with hypoparathyroidism presented at endo 2023
– Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported...
June 17, 2023, 9:30 pm
transcode therapeutics announces closing of $7 million public offering
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company�...
June 9, 2023, 8:05 pm
transcontinental inc. (tclaf) q2 2023 earnings call transcript
transcontinental Inc. (OTCPK:TCLAF) wQ2 2023 Earnings Conference Call June 8, 2023 4:15 PM ET Company P...
June 8, 2023, 1:54 am
transcode therapeutics announces pricing of $7 million public offering
BOSTON, June 06, 2023 (GLOBE NEWSWIRE) — transcode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company�...
June 6, 2023, 9:29 pm
Ascendis pharma opens compassionate use program for transcon™ pth (palopegteriparatide) in germany
– Compassionate use enables treating physicians in Germany to request access to investigational transco...
June 5, 2023, 9:30 pm